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the study. Symptom severity was assessed using the gastroparesis cardinal symptom 
index.	Autonomic	function	testing	was	performed	at	baseline	enrollment	using	the	
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1  | INTRODUC TION
Gastroparesis	 is	 a	 heterogeneous	 disorder	 defined	 as	 delayed	
gastric	 emptying	 in	 the	 absence	 of	 a	 mechanical	 obstruction.	
Symptoms	of	gastroparesis	are	variable	and	include	nausea,	vom-
iting,	 early	 satiety,	 bloating,	 postprandial	 fullness,	 abdominal	
pain/discomfort,	 and	 anorexia.1-4	 However,	 there	 is	 poor	 corre-
lation	 between	 severity	 of	 gastroparesis	 symptoms	 and	 the	 de-
gree	of	delayed	gastric	emptying.5-7	Gastroparesis-like	syndrome	
or	chronic	unexplained	nausea	and	vomiting	(CUNV)	is	a	disorder	
such that patients present with symptoms similar to those with 
gastroparesis but have normal gastric emptying.8 The pathophysi-
ology	of	gastroparesis	and	CUNV	have	yet	to	be	fully	elucidated.	
Abnormalities	of	gastric	smooth	muscle,	interstitial	cells	of	Cajal,	




Parasympathetic	 control	 is	 mediated	 through	 the	 vagus,	 while	
sympathetic	control	 is	mediated	through	the	spinal	cord	at	T5	to	





The	 autonomic	 nervous	 system	 (ANS)	 is	 responsible	 for	 inte-
grating the external environment and maintaining homeostasis via a 
complex	system	of	reflex	responses	to	alterations	in	organ	function.	
Autonomic	dysfunction	can	 lead	to	alterations	 in	homeostasis	and	




tonomic	 dysfunction,	 gastric	 emptying	 scintigraphy	 revealed	 both	
rapid	and	delayed	gastric	emptying,	with	rapid	gastric	emptying	oc-
curring more commonly.18	 In	 this	 study,	demographics,	 symptoms,	
and	 severity	 of	 autonomic	 dysfunction	did	 not	 predict	 the	 gastric	
emptying	abnormality.	Thus,	 the	 role	of	 autonomic	dysfunction	 in	
gastroparesis as it relates to gastric emptying and symptoms remains 
unclear.
The	ANS	and	symptoms	of	gastroparesis	can	be	altered	by	many	









Two	 hundred	 and	 forty-two	 patients	 with	 gastroparesis	 and	
CUNV	were	recruited	at	eight	centers	of	the	NIDDK	Gastroparesis	
Clinical	Research	Consortium	 into	Gastroparesis	Registry	2	from	




toms was determined to be either diabetic or idiopathic in origin. 
Patients	with	postsurgical	gastroparesis	were	excluded	from	this	
study.	 Gastric	 emptying	 scintigraphy	 was	 performed	 on	 all	 pa-
tients	within	6	months	of	enrollment.	Patients	with	symptoms	of	
gastroparesis and normal gastric emptying make up the popula-
tion	of	patients	defined	as	CUNV	or	gastroparesis-like	syndrome.	





in more severe symptoms and delayed gastric emptying.
K E Y W O R D S
autonomic	function,	dysautonomia,	gastric	emptying,	gastroparesis,	heart	rate	variability
Key Points
• Chronic upper gastrointestinal symptoms are asso-
ciated with both sympathetic and parasympathetic 
dysfunction.
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Patients	 were	 also	 excluded	 if	 other	 conditions	 were	 present	
that	 could	 explain	 their	 symptoms	 (obstruction,	 active	 inflam-
matory	 bowel	 disease,	 eosinophilic	 gastroenteritis,	 connective	
tissue	disease,	 neurologic	disease,	 chronic	 liver	or	 renal	 disease,	













at	 rest	and	 following	challenges	 to	 the	sympathetic	and	parasym-
pathetic	 system:	 5	 minutes	 of	 rest,	 1	 minute	 of	 deep	 breathing	
(parasympathetic	challenge),	1	minute	of	short	Valsalva	maneuvers	
(sympathetic	 challenge),	 following	by	a	 rapid	 stand	and	5	minutes	
of	 standing	 quietly	 (sympathetic	 and	 parasympathetic	 challenge).	
Each	challenge	is	separated	by	a	1-minute	period	of	return	to	base-
line.	 HRV	 and	 respiratory	 activity	 were	 measured	 concurrently	
with	 analyses	 performed	 both	 independently	 and	 simultaneously	
to	 compute	 parasympathetic	 and	 sympathetic	 activity.	 HRV	 was	
computed	 from	 a	 rhythm	 strip,	 which	measures	 beat-to-beat	 R-R	
intervals,	while	respiratory	activity	was	recorded	using	impedance	
plethysmography according to standard methods.23,24 Autonomic 
parameters	computed	by	the	ANX	3.0	system	included	the	follow-
ing	parameters:	 sympathetic	 activity	 (LFa),	 parasympathetic	 activ-
ity	(RFa),	and	sympathovagal	balance	(LFa/RFa).	Table	1	lists	normal	






sympathetic	 excess	 (LFa	 >28.0	 during	 valsalva	 or	 upon	 standing),	
low	 parasympathetic	 response	 to	 challenge	 (deep	 breathing,	 RFa	
<28.0),	and	challenge	parasympathetic	excess	(RFa	increase	>400%	
over	 baseline	 during	 valsalva,	 or	 any	 RFa	 increase	 with	 standing	
compared	 to	baseline).	Under	normal	 conditions,	 the	PNS	activity	





is	 1.0	 (range:	 0.4-3.0).	 An	 elevated	 LFa/RFa	 indicates	 either	 sym-
pathetic	 excess	 of	 parasympathetic	 hypofunction,	while	 low	 LFa/
RFa	indicates	either	sympathetic	hypofunction	or	parasympathetic	
excess. The sympathovagal balance can be normal despite abnormal 
values	of	both	sympathetic	and	parasympathetic	function.	Postural	










test based on consensus guidelines26	 Patients	were	 categorized	
into normal vs delayed gastric emptying while those with rapid 
gastric	 emptying	 (1	 hour	 retention	<30%)	were	 excluded	 due	 to	
inadequate	numbers	(N	=	14).
2.4 | Data acquisition
Demographic	 information,	 medical	 history,	 presence	 of	 absence	
of	 diabetes,	 physical	 examination,	 symptom	 severity	 (Patient	
Assessment	 of	 Upper	 Gastrointestinal	 Disorders	 [PAGI-SYM]),27 
Beck	 depression,28	 and	 State-Trait	 anxiety	 questionnaires	 were	
obtained	at	the	time	of	enrollment.	Gastroparesis	and	CUNV	se-
verity was determined by the Gastroparesis Cardinal Symptom 
Index	 (GCSI),	which	 includes	nine	questions	 from	the	PAGI-SYM	
that	 is	 grouped	 into	 three	 symptom	subscales	 (nausea/vomiting,	
postprandial	 fullness/early	 satiety,	 and	 bloating).29	 Severity	 of	
symptoms	was	rated	on	a	six	point	scale	from	0	to	5:0	(no	symp-
toms),	1	(very	mild),	2	(mild),	3	(moderate),	4	(severe),	and	5	(very	
severe).	 Severe	 symptoms	are	defined	as	an	average	GCSI	 score	
(total	or	subscales)	≥4.	Severity	of	gastroparesis	or	CUNV	symp-
toms	was	also	graded	as	mild	(controlled	with	diet),	compensated	
(requiring	promotility	 and	anti-emetics)	or	gastric	 failure	 (requir-
ing	 hospitalization,	 enteral,	 or	 parenteral	 nutritional	 support)	 as	
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performed	 on	 the	 upper	 abdominal	 pain	 component	 of	 the	 PAGI-
SYM	and	the	graded	gastroparesis	symptom	severity	determination.	
Analyses	 for	 each	 parameter	 were	 performed	 on	 the	 entire	 cohort	
with	additional	subgroup	analyses	performed	based	on	etiology	and	
gastric	emptying	status.	Due	to	non-normality,	values	are	presented	
as	 median	 (IQR),	 and	 P-values	 were	 derived	 from	 linear	 regression	





sion analysis was used to measure the association between autonomic 
abnormality	and	two	outcome	measures:	etiology	of	gastroparesis	and	
CUNV	symptoms	(diabetic	vs	idiopathic)	and	symptom	severity	(GCSI	













Sympathetic response to stand LFa	increase	between	10%	and	500%	over	
baseline during stand
TA B L E  1  Definition	of	normal	ANX	3.0	
autonomic measures25
Characteristic
Etiology of upper GI symptoms
Total





Age	(years)	–	mean	(SD) 45	(11) 42	(13) 43	(13) .12
Gender
Male 13	(21%) 16	(9%) 29	(12%) .02
Female 50	(79%) 163	(91%) 213	(88%)
Ethnicity
Hispanic/Latino 14	(22%) 19	(11%) 33	(14%) .02
Not	Hispanic/Latino 49	(78%) 160	(89%) 209	(86%)
Race
White 54	(86%) 161	(90%) 215	(89%) .05
Black 8	(13%) 9	(5%) 17	(7%)




More than one race 0	(0%) 6	(3%) 6	(2%)
BMI	–	mean	(SD) 31.0	(8.5) 26.7	(7.6) 27.8	(8.1) <.001
Gastric emptying
Normal 12	(19%) 55	(31%) 67	(28%) .10
Delayed 51	(81%) 124	(69%) 175	(72%)  
Smoking history
Current smoker 7	(11%) 25	(14%) 32	(13%) .67
Ever	smoker 28	(44%) 57	(32%) 85	(35%) .09
State-trait	anxiety
Mod/severe state anxiety 35	(56%) 85	(47%) 120	(47%) .31
Mod/severe trait anxiety 36	(57%) 86	(48%) 122	(50%) .24
TA B L E  2  Demographics	and	baseline	
patient characteristics
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≥4	vs	GCSI	<4),	 adjusting	 for	age,	gender,	Hispanic/Latino	ethnicity,	
race	 (white	 vs	 non-white),	 depression	 (beck	 depression	 inventory	
score	>19	vs	≤19,	indicating	moderate	depression),	anxiety	(State-Trait	


















74%	 (N	=	 179)	 had	 symptoms	 that	were	 idiopathic	 in	 origin	 and	
26%	(N	=	63)	had	symptoms	related	to	complications	of	diabetes.	
Patients	were	 predominantly	 female	 (N	 =	 213	 [88%])	with	more	
women	in	the	idiopathic	group	[Table	2]).	The	majority	of	patients	
in both groups had delayed gastric emptying (P	=	.10).	Autonomic	
function	 differed	 between	 men	 and	 women,	 such	 that,	 women	
exhibited greater parasympathetic activity as demonstrated by 
the lower resting sympathovagal balance and greater standing 
parasympathetic	activity	(Table	S1).	Only	four	patients	in	the	en-
tire	cohort	met	criteria	 for	postural	orthostatic	 tachycardia	 syn-
drome	by	ANX	3.0	criteria.
3.2 | Differences in autonomic function by etiology
At	least	one	abnormal	autonomic	measure	was	found	in	the	major-
ity	of	patients.	Sympathetic	withdrawal	(low	sympathetic	response	






















mean HgA1c was similar in patients with diabetes and challenge para-







3.4 | Significance of autonomic dysfunction and 
upper GI symptom severity and subtypes
Thirty-five	 (14.5%)	 patients	 reported	 severe	 symptoms	 of	 gastropa-
resis	defined	as	an	average	total	GCSI	≥4.	Patients	with	more	severe	
symptoms	of	gastroparesis	were	found	to	have	a	higher	resting	sym-
pathovagal	balance	 (LFa/RFa	1.8	 [1.0-3.1]	vs	1.2	 [0.6-2.3],	P	=	 .006),	
which	can	be	a	reflection	of	either	decreased	resting	parasympathetic	
or	 increased	 resting	 sympathetic	 activity	 (Table	5).	 The	presence	of	





























6 of 9  |     NGUYEN Et al.
lower	standing	parasympathetic	activity	(RFa)	in	patients	with	severe	
upper	GI	 symptoms	 (0.4	 [0.1-0.8]	 vs	0.6	 [0.2-1.7],	P	 =	 .03)	 suggests	
that	the	higher	sympathovagal	balance	(LFa/RFa	ratio)	is	due	to	lower	
parasympathetic	 activity.	 Conversely,	 patients	with	milder	 upper	GI	
symptoms	were	found	to	have	a	lower	sympathovagal	balance	in	the	





compared	 to	 those	with	grade	2	 (15%)	and	grade	3	 (25%)	 symptom	
severity (P	 =	 .004).	 Taken	 together,	 patients	 with	 milder	 upper	 GI	
symptoms tend to have lower sympathetic activity while patients with 
severe symptoms tend to have lower parasympathetic activity.










vomiting	 and	 bloating	 but	 not	 fullness/early	 satiety.	 Diabetics	 re-
porting	severe	symptoms	of	nausea/vomiting	had	lower	sympathetic	
and	parasympathetic	activity	with	standing.	 (Table	S3)	Conversely,	
idiopathic	 patients	 reporting	 severe	 symptoms	 of	 bloating	 had	 a	
higher	resting	sympathovagal	balance	(Table	S4).	Subgroup	analyses	
separating	those	with	normal	or	delayed	gastric	emptying	(Table	S5)	
found	that	 the	autonomic	abnormalities	were	more	 likely	 found	 in	
those with delayed gastric emptying than those with normal gastric 
emptying.	 There	were	 no	 differences	 comparing	 upper	 abdominal	
pain	 by	 PAGI-SYM	 (Table	 S6)	 or	 predominant	 symptom	 (nausea/
vomiting	predominant	vs	pain	predominant)	(Table	S7).
4  | DISCUSSION
Autonomic	 dysfunction	 (predominantly	 vagal/parasympathetic	 hy-
pofunction)	has	been	described	in	gastroparesis31,32	and	functional	
dyspepsia.22 This is the largest prospective study that systematically 
assesses both sympathetic and parasympathetic activity in patients 
with chronic symptoms suggestive gastroparesis (gastroparesis and 





tion	at	 rest	and	 in	 response	 to	challenge	maneuvers,	 (c)	paradoxic	




In	 our	 study	 using	 an	 office-based	 tool	 that	 measures	 both	
branches	of	the	ANS,	our	study	found	abnormalities	in	sympathetic	
and	parasympathetic	function,	which	are	similar	to	two	smaller	stud-








(N = 175) P
Low	resting	sympathetic	activity 7	(10%) 42	(24%) .02
Resting sympathetic excess 6	(9%) 18	(10%) 1.00
Low	resting	parasympathetic	activity 13	(19%) 54	(31%) .08
Resting parasympathetic excess 4	(6%) 16	(9%) .60
Low	sympathetic	response	to	challenge 49	(79%) 128	(78%) .86
Challenge sympathetic excess 2	(4%) 16	(11%) .16
Challenge parasympathetic excess 17	(26%) 69	(40%) .05
TA B L E  4   Autonomic abnormalities 
comparing patients with delayed vs 
normal gastric emptying
TA B L E  5  Comparison	of	autonomic	activity	in	patients	with	
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assessed	 by	 testing	 both	 the	 preganglionic	 adrenergic	 fibers	 (per-
cent	reflex	vasoconstriction	to	cold)	and	the	postganglionic	choliner-
gic	fibers	(basal	and	cold	exposed	skin	temperature).	In	a	study	of	12	
patients	with	 diabetes	 and	 symptoms	 suggestive	 of	 gastroparesis,	
Abell et al32	found	abnormalities	in	both	sympathetic	and	parasym-
pathetic	function	 in	patients	with	diabetic	gastroparesis	compared	
to healthy controls and diabetics without gastroparesis. This study 
found	 that	 impairment	 in	 reflex	 vasoconstriction	 (sympathetic	 hy-
pofunction)	was	associated	impairment	in	gastric	emptying	(r	=	.79,	
P	<	.01).	Similar	to	this	study	by	Abell	et	al,32	our	study	found	that	
patients with delayed gastric emptying were more likely to exhibit 
low resting sympathetic activity than those with normal gastric emp-
tying.	However,	using	multiple	 regression	analyses	 that	accounted	
for	etiology	of	gastroparesis,	the	presence	of	delayed	gastric	emp-
tying was only associated with challenge parasympathetic excess in 
diabetic but not idiopathic gastroparesis. This is similar to the study 
by	Mohammad	 et	 al,31	 comparing	 diabetic	 (N	 =	 20)	 vs	 idiopathic	
(N	 =	 21)	 gastroparesis.	 They	 too	 found	 that	 diabetics	 had	 greater	
parasympathetic	 hypofunction	 with	 reduced	 heart	 rate	 variability	
(%R-R	 interval	 change	with	 respiration:	 8%	vs	33%,	P	 <	 .001)	 and	







related	 to	 diabetes	 rather	 than	 an	 independent	 marker	 of	 gastric	
emptying delay.




emptying while the other 39% had delayed gastric emptying. This 
study	measured	cardiovagal	 (parasympathetic),	adrenergic	 (sympa-
thetic),	 and	 sudomotor	 (sweat)	 function.	Results	of	 the	autonomic	
testing were used to calculate the composite autonomic scoring 






emptying	due	to	 inadequate	numbers	 (N	=	14)	 to	perform	statisti-
cally	meaningful	analyses.
Using	 multiple	 logistic	 regression	 analyses	 that	 accounted	 for	
various	 factors	 that	 impact	autonomic	 function,	 including	etiology	
of	 gastroparesis,	 our	 study	 found	 that	 a	 higher	 resting	 sympatho-
vagal	 balance	 (LFa/RFa)	 was	 associated	 with	 more	 severe	 upper	
GI	symptoms	in	patients	with	idiopathic	but	not	diabetic	causes	of	




severe	upper	GI	 symptoms,	 the	data	 suggest	 that	 the	higher	 LFa/










was	 a	 progression	 of	 diabetic	 autonomic	 neuropathy	 that	 started	
with	 parasympathetic	 hypofunction,	 followed	 by	 sympathetic	 ex-
cess,	sympathetic	hypofunction,	 impaired	quality	of	 life,	overt	dia-
betic	 autonomic	neuropathy,	 and	 finally,	 cardiovascular	 autonomic	
neuropathy with arrhythmias.34,35	 Our	 study	 also	 demonstrated	
that	diabetics	with	more	severe	symptoms	of	nausea/vomiting	were	
found	 to	 have	 lower	 challenge	 sympathetic	 and	 parasympathetic	
activity,	which	suggests	that	severe	nausea	and	vomiting	in	diabet-
ics is associated with a more generalized cardiovascular autonomic 
neuropathy.	 These	 disparate	 autonomic	 findings	 may	 reflect	 the	
differing	pathophysiology	of	diabetic	vs	idiopathic	gastroparesis	or	
differences	in	the	cardiac	and	gastrointestinal	branches	of	the	vagus.
A	 limitation	of	our	study	 is	 that	HRV	 is	an	 indirect	measure	of	




tion	 is	 representative	 of	 gastrointestinal	 autonomic	 dysfunction.	
This	 assumption	 is	 supported	by	a	 study	of	diabetics	with	 cardiac	
autonomic	neuropathy	determined	by	HRV,	which	 found	 that	 car-
diac autonomic neuropathy was associated with decreased gastric 
acid	 output	 and	 pancreatic	 polypeptide	 stimulated	 by	 sham	 feed-
ing.37	 Our	 study	 is	 also	 limited	 by	 the	 lack	 of	 simultaneous	mea-
surements	of	 autonomic	 function,	 gastric	emptying,	 and	 symptom	







a more generalized autonomic neuropathy.
Although	 the	 presence	 of	 autonomic	 dysfunction	 or	 sympa-






ing	 treatments	 that	 restore	balance	 to	 the	ANS.	For	example,	 in	a	
study	 assessing	 the	 impact	 of	 neurostimulation	 on	 gastroparesis	
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symptoms	 and	 autonomic	 parameters,	 Stocker	 et	 al36	 found	 that	
neurostimulation	increased	vagal	cholinergic	(parasympathetic)	and	
decreased	 sympathetic	 adrenergic	 activity	 (sympathetic).	 As	 such,	
neurostimulation may not be the ideal choice in patients with para-
sympathetic	excess	or	sympathetic	hypofunction.
In	 summary,	 our	 present	 study	 found	 that	 measures	 of	 auto-
nomic	 dysfunction	were	 common	 among	 patients	with	 symptoms	
of	 gastroparesis	 and	 CUNV.	 Not	 surprisingly,	 those	with	 diabetes	





that	 gastroparesis	 and	CUNV	may	be	a	manifestation	of	 gastroin-
testinal	autonomic	dysfunction	or	imbalance,	such	that	sympathetic	
dysfunction	 occurs	 early	 on	 in	 the	manifestation	 of	 gastroparesis	
and	CUNV,	while	parasympathetic	dysfunction	results	 in	more	se-
vere symptoms and delayed gastric emptying.
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